BioSpace News Archive

Regeneron Pharmaceuticals, Inc. and Sanofi announced the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to Dupixent® for the treatment of patients 12 years and older with eosinophilic esophagitis.

Dynavax will provide CpG 1018 to produce up to 190 million doses over a five year period to support Valneva’s contract with the U.K. government

Société des Produits Nestlé S.A. announced that its wholly-owned subsidiary, SPN Merger Sub, Inc., is commencing a cash tender offer to purchase all of the outstanding shares of common stock of Aimmune Therapeutics, Inc. today for a price of USD 34.50 per share, net to the seller in cash, without interest and subject to any withholding taxes.

The ability to speak with a pharmacist has become increasingly difficult in recent years, as most licensed pharmacists have little or no time to interact with patients and doctors.

Presentation to highlight the scientific characteristics of the novel first-in-class anti Globo H antibody-drug conjugate (ADC), OBI-999